Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.
Impact
The bill requires a standing order from the chief medical officer at hospitals, directing them to provide both verbal and written information regarding hepatitis C screening policies approved by the CDC. If consented by the individual, the required laboratory services will include performing the hepatitis C test and communicating results to the referring healthcare provider. Moreover, hospitals must follow up with patients who test positive to encourage subsequent medical care, aiming to enhance public health responses to this chronic illness and improve overall health outcomes for this vulnerable population.
Summary
Senate Bill 2475, sponsored by Senator Nilsa I. Cruz-Perez, establishes new requirements for hepatitis C testing in New Jersey. Targeting individuals born between January 1, 1945, and December 31, 1965, the bill mandates that hospital laboratories and bio-analytical or clinical laboratories offer hepatitis C screenings to this demographic. This initiative is rooted in findings from the CDC, which indicates that a significant portion of those infected with hepatitis C are unaware of their status and that such screenings can potentially mitigate severe health outcomes, including liver cancer and liver transplants.
Contention
While the bill primarily seeks to improve healthcare access and early detection of hepatitis C, its implementation might also raise questions regarding health insurance reimbursements and the financial burden on laboratories. When laboratories are out-of-network with a patient's health benefits plan, reimbursement must align with in-network rates. This provision aims to alleviate costs for patients; however, it necessitates vigorous checks on laboratory records to avoid unnecessary screenings, thereby balancing patients' access to testing with effective management of healthcare costs.
Provisions
The bill is set to take effect on January 1 following its enactment, and it includes a review by the Commissioner of Health within a year to evaluate screening outcomes and patient follow-up rates. Regulations will also be developed to allow licensed laboratories to conduct rapid point-of-care tests, thereby expanding the scope and accessibility of hepatitis C testing significantly in New Jersey.
Carry Over
Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.